Intas Pharmaceuticals Limited

For profitWebsite ↗

Also known as: Intas Pharmaceutical Limited (Biopharma Division) | Intas Pharmaceuticals Limited | Intas Pharmaceuticals, Ltd. | INTAS PHARMS LTD | INTAS PHARMS USA

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Feb 12, 2018

First marketed drug

Aug 31, 2017

Last known activity

Oct 13, 2022

Timeline

1980s

Jun 1, 1984
Intas Pharmaceuticals Limited— Founded

2010s

Aug 31, 2017
irinotecan— Marketing Organization

Drugs by trial phase (4 distinct, 5 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Filgrastim

Indications

Studied for

Marketed drugs (3)

Recent trials (7)

NCT05419427CollaboratorPhase 3Nov 11, 2021
NCT04315792CollaboratorPhase 3Mar 23, 2020
NCT03671044CollaboratorPhase 3Jul 10, 2018
NCT04015232Study directorPhase 1Feb 26, 2018
NCT04015232Lead sponsorPhase 1Feb 26, 2018
NCT04014062Study directorPhase 1Feb 12, 2018
NCT04014062Lead sponsorPhase 1Feb 12, 2018

Details

Founded: Ahmedabad, IN Jun 1, 1984
Last known activity: Oct 13, 2022